Contact this trialFirst, we need to learn more about you.
Biomarker Monitoring for Breast Cancer Recurrence Risk
Recruiting1 award7 criteria
Philadelphia, Pennsylvania
This trial is for women who have completed therapy for breast cancer within 5 years of diagnosis and are at increased risk for relapse. Patients will have a bone marrow aspirate to test for presence of disseminated tumor cells (DTCs). If they have DTCs, they will be offered enrollment into a clinical trial of therapy targeting DTCs to prevent recurrence.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service